Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Osteoporosis 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Uterine Cervical Dysplasia 1Precancerous Conditions 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1Hereditary Breast and Ovarian Cancer Syndrome 1

Interventions

Colposcopy 5Polymerase Chain Reaction 4Biopsy 4Watchful Waiting 2Vaginal Smears 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Histological Techniques 2Cidofovir 2human papillomavirus vaccine, TA 1human papillomavirus vaccine, L1 type 16, 18 1Zoledronic Acid 1Tretinoin 1Transurethral Resection of Prostate 1Spectrum Analysis 1Spectrometry, Fluorescence 1Sodium Chloride 1Robotic Surgical Procedures 1Radiotherapy 1Pregnancy Tests 1Papanicolaou Test 1Mindfulness-Based Stress Reduction 1Microarray Analysis 1Immunohistochemistry 1Hysterectomy 1Human Papillomavirus DNA Tests 1Gene Expression Profiling 1Folic Acid 1Fluorophotometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Zoledronic Acid × Gynecologic × Clear all
NCT00278434 2017-11-24

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

University of California, San Francisco

Phase 1 Terminated
12 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡